首页 › 超重 › 南卡罗来纳州 › Greenville
Greenville SC 超重临床试验
8项针对 超重的研究正在 Greenville及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Tribe Clinical Research LLC Dba Mountain View Clinical Research, Greenville
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
招募中3 期
- Prisma Health-Ped Endo, Greenville
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
招募中2 期
- Tribe Clinical Research, Greenville
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Gastroenterology Associates - Patewood, Greenville
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
招募中3 期
- Gastroenterology Associates - Patewood, Greenville
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
招募中2 期
- Tribe Clinical Research, LLC, Greenville
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
招募中3 期
- Tribe Clinical Research, LLC, Greenville
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
招募中2 期
- Tribe Clinical Research, LLC, Greenville
其他城市的 超重试验
- San Antonio, TX34 项研究
- Houston, TX33 项研究
- Chicago, IL29 项研究
- Orlando, FL27 项研究
- Las Vegas, NV23 项研究
- Miami, FL23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Greenville的其他研究
- 非小细胞肺癌15 项研究
- 乳腺癌12 项研究
- 急性髓系白血病10 项研究
- 癌症（所有类型）9 项研究
- 肥胖症9 项研究
- 肺癌9 项研究
- 前列腺癌7 项研究
- 结直肠癌7 项研究
- 胃癌6 项研究
- 外周动脉疾病5 项研究
- 伯基特淋巴瘤5 项研究
- 黑色素瘤5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。